Michael Glickman

Michael Glickman is a Professor at Memorial Sloan Kettering Cancer Center (MSKCC) with a dual appointment in the Department of Medicine and Gerstner Sloan Kettering Graduate School of Biomedical Sciences. He holds an MD from Columbia University College of Physicians and Surgeons and leads the Michael Glickman Lab, focusing on mycobacterial biology, tuberculosis pathogenesis, and BCG immunotherapy mechanisms.

• Research Interests:
  • Mycobacterial proteostasis systems
  • DNA repair and mutagenesis
  • BCG-induced anti-tumor immunity
  • Microbiome-tuberculosis interactions
• Key Article Trends:
  • 2025 studies highlight ALFA tagging, metal resistance, and immune reprogramming
  • 2024 work explores TNF deficiency in TB and DnaK-GrpE structural dynamics
  • 2023 research addresses Rip1 protease roles in metal homeostasis
• Labs & Collaborations:
  • Immunology Program
  • Collaborations with Weill Cornell Medicine and GHESKIO Center
  • Active postdoctoral opportunities

Advising & Grants: Mentors PhD students and postdocs; funded by NIH grants AI53417, R01 AI080628, and P30 CA008748. His lab investigates host immune sensing, microbiome dynamics, and mycobacterial virulence pathways.